Precision Medicine: From Population-Based to Patient Focused Drug Therapy

The UMB Student Chapter of the International Society for Pharmacoepidemiology is pleased to sponsor a keynote speaker, Bruce Carleton, PharmD, Professor of Pediatrics, Co-Chair of the Division of Translational Therapeutics, Faculty of Medicine, University of British Columbia. His clinical research interests include epidemiology and pharmacogenomics, with an emphasis on pediatric medicine and the epidemiology and clinical management of adverse drug reactions. He has received funding from the Canadian Institute of Health Research for several projects including Drug Safety and Effectiveness Network (DSEN) in Adverse Drug Reaction Active Surveillance and Pharmacogenomics of Adverse Drug Reactions. These projects investigate the safety of inhaled corticosteroids in children and pregnant women and to apply new pharmacogenetic methods to better understand anthracycline-induced cardiotoxicity. Dr.Carleton’s lecture focuses on the transition from population-based care to patient focused drug therapy through the implementation of genetic risk prediction models in clinical care. Graduate students are also invited to journal club and lunch with Dr.Carleton. Dr.Carelton's lecture will be held on Thursday, May 4th, in Pharmacy Hall N111 @4 pm. The graduate student lunch is on Thursday, May 4th at 12 pm in the Saratoga Building 13th Floor, room 02-201